NYSE American - Delayed Quote USD
CEL-SCI Corporation (CVM)
2.3700
-0.1100
(-4.44%)
At close: June 12 at 4:00:00 PM EDT
2.3500
-0.02
(-0.84%)
Pre-Market: 5:28:56 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | 0 | 0 | -12.3 | 0 |
| Low Estimate | 0 | 0 | -12.3 | 0 |
| High Estimate | 0 | 0 | -12.3 | 0 |
| Year Ago EPS | -- | -- | -15.3 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 1 |
| Avg. Estimate | -- | -- | -- | 7.7M |
| Low Estimate | -- | -- | -- | 7.7M |
| High Estimate | -- | -- | -- | 7.7M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -- | -4.2 | -3.9 | -3.3 |
| EPS Actual | -4.2 | -8.4 | -4.2 | -2.7 |
| Difference | -- | -4.2 | -0.3 | 0.6 |
| Surprise % | -- | -100.00% | -7.69% | 18.18% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -12.3 | 0 |
| 7 Days Ago | 0 | 0 | -12.3 | 0 |
| 30 Days Ago | 0 | 0 | -14.4 | 0 |
| 60 Days Ago | 0 | 0 | -14.4 | 0 |
| 90 Days Ago | 0 | 0 | -14.4 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CVM | -- | -- | 19.61% | -- |
| S&P 500 | 13.13% | 2.45% | 7.55% | 14.06% |
Upgrades & Downgrades
| Reiterates | EF Hutton: Buy to Buy | 7/12/2023 |
| Reiterates | EF Hutton: Buy | 3/9/2023 |
| Maintains | EF Hutton: Buy | 12/29/2022 |
| Initiated | EF Hutton: Buy | 4/7/2022 |
| Initiated | HC Wainwright & Co.: Buy | 1/13/2020 |
| Initiated | Taglich Brothers: Speculative Buy | 2/20/2013 |
Related Tickers
IMMX Immix Biopharma, Inc.
2.4900
+1.84%
NWBO Northwest Biotherapeutics, Inc.
0.2600
0.00%
OVID Ovid Therapeutics Inc.
0.2893
-9.25%
BCLI Brainstorm Cell Therapeutics Inc.
1.1800
-4.84%
ENSC Ensysce Biosciences, Inc.
2.1400
+3.63%
TNFA TNF Pharmaceuticals, Inc.
0.1532
-6.76%
PCSA Processa Pharmaceuticals, Inc.
0.3443
-13.93%
QLGN Qualigen Therapeutics, Inc.
3.8220
+0.63%
QNRX Quoin Pharmaceuticals, Ltd.
8.47
-0.24%
CYDY CytoDyn Inc.
0.3600
+2.86%